Joy Olbertz

442 total citations · 1 hit paper
10 papers, 301 citations indexed

About

Joy Olbertz is a scholar working on Molecular Biology, Clinical Biochemistry and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Joy Olbertz has authored 10 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Clinical Biochemistry and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Joy Olbertz's work include Metabolism and Genetic Disorders (5 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Blood disorders and treatments (2 papers). Joy Olbertz is often cited by papers focused on Metabolism and Genetic Disorders (5 papers), Cardiac electrophysiology and arrhythmias (2 papers) and Blood disorders and treatments (2 papers). Joy Olbertz collaborates with scholars based in United States and United Kingdom. Joy Olbertz's co-authors include Haoling H. Weng, Soumi Gupta, Kevin Larimore, Cary O. Harding, Roberto T. Zori, Markus Meriläinen, Janet A. Thomas, Jerry Vockley, Harvey L. Levy and Hope Northrup and has published in prestigious journals such as New England Journal of Medicine, Annals of the New York Academy of Sciences and EBioMedicine.

In The Last Decade

Joy Olbertz

10 papers receiving 293 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy

2024 41 citations Marianna Fontana, Scott D. Solomon et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joy Olbertz United States	7	180	178	107	41	28	10	301
Mary Anne Preece United Kingdom	11	162 0.9×	166 0.9×	75 0.7×	66 1.6×	46 1.6×	20	377
Alexander Laemmle Switzerland	10	194 1.1×	82 0.5×	71 0.7×	14 0.3×	16 0.6×	19	412
Jamiyan Purevsuren Japan	14	373 2.1×	384 2.2×	75 0.7×	55 1.3×	38 1.4×	25	513
Shailly Jain‐Ghai Canada	6	114 0.6×	100 0.6×	81 0.8×	22 0.5×	13 0.5×	11	230
Sylvia Stoeckler-Ipsiroglu Austria	8	121 0.7×	139 0.8×	68 0.6×	30 0.7×	20 0.7×	11	247
Fatma Al Jasmi United Arab Emirates	9	74 0.4×	76 0.4×	53 0.5×	58 1.4×	20 0.7×	18	195
W. Oostheim Netherlands	13	398 2.2×	266 1.5×	60 0.6×	35 0.9×	49 1.8×	16	550
Andrew A. M. Morris United Kingdom	12	176 1.0×	129 0.7×	30 0.3×	86 2.1×	18 0.6×	15	372
Keow Giak Sim Australia	12	335 1.9×	399 2.2×	94 0.9×	105 2.6×	47 1.7×	13	512
Sommer Gaughan United States	4	91 0.5×	124 0.7×	42 0.4×	69 1.7×	63 2.3×	10	239

Countries citing papers authored by Joy Olbertz

Since Specialization

Citations

This map shows the geographic impact of Joy Olbertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Olbertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Olbertz more than expected).

Fields of papers citing papers by Joy Olbertz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy Olbertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Olbertz. The network helps show where Joy Olbertz may publish in the future.

Co-authorship network of co-authors of Joy Olbertz

This figure shows the co-authorship network connecting the top 25 collaborators of Joy Olbertz. A scholar is included among the top collaborators of Joy Olbertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joy Olbertz. Joy Olbertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Fontana, Marianna, Scott D. Solomon, Liron Walsh, et al.. (2024). CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy. New England Journal of Medicine. 391(23). 2231–2241. 41 indexed citations breakdown →

2.

Zhou, Huiyu, Johanna R. Abend, Joy Olbertz, et al.. (2021). Achieving efficacy in subjects with sustained pegvaliase-neutralizing antibody responses. Molecular Genetics and Metabolism. 134(3). 235–242. 4 indexed citations

3.

Henshaw, Joshua, Soumi Gupta, Joy Olbertz, et al.. (2021). Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria. Clinical and Translational Science. 14(5). 1894–1905. 14 indexed citations

4.

Berguig, Geoffrey Y., Nathan Martin, Lin Xie, et al.. (2019). Of mice and men: Plasma phenylalanine reduction in PKU corrects neurotransmitter pathways in the brain. Molecular Genetics and Metabolism. 128(4). 422–430. 15 indexed citations

5.

Thomas, Janet A., Harvey L. Levy, Stephen Amato, et al.. (2018). Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM). Molecular Genetics and Metabolism. 124(1). 27–38. 134 indexed citations

6.

Gupta, Soumi, Cary O. Harding, Gillian Shepherd, et al.. (2018). Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials. EBioMedicine. 37. 366–373. 59 indexed citations

7.

Olbertz, Joy, et al.. (2016). Early drug development: assessment of proarrhythmic risk and cardiovascular safety. Expert Review of Clinical Pharmacology. 9(12). 1611–1618. 19 indexed citations

8.

Moore, Keith A., Timothy S. Callahan, Pierre Maison‐Blanche, et al.. (2010). Thorough cardiac QTc interval conductance assessment of a novel oral tranexamic acid treatment for heavy menstrual bleeding. Expert Opinion on Pharmacotherapy. 11(14). 2281–2290. 9 indexed citations

9.

Olbertz, Joy, et al.. (2008). Apoptotic resistance exhibited by dexamethasone-resistant murine 7TD1 cells is controlled independently of interleukin-6 triggered signaling. APOPTOSIS. 13(11). 1394–1400. 4 indexed citations

10.

Rose, Jack, et al.. (1999). Plasma β‐Endorphin Concentrations During Natural and Artificially Induced Winter Hair Growth in Mink (Mustela vison). Annals of the New York Academy of Sciences. 885(1). 440–443. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact